Navigation Links
Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]
Date:7/21/2011

NEW YORK, July 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

http://www.reportlinker.com/p0574385/Pharmaceutical-Preparation-Manufacturing-Industry-in-the-US-and-its-International-Trade-[2011-Q3-Edition].html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_

This latest Pharmaceutical Preparation Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and downstream industries, and trade data.

This 2011 report's 174 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through July 2011. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2015. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report.

In this report, you will find industry data on the following major categories:

Executive Summary

  • Quick Industry Statistics: 2-page overview for the CEO on the run

  • Supply & Demand with Capacity Utilization

  • 2011-2015 Forecast

Industry Income Statement

  • All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.

  • 4-year Financials Comparison and Trends

Industry Balance Sheet

  • Traditional key elements of Assets, Liabilities, and Equity

  • Inventory fabrication stages

  • Calculated balance sheet ratios

Capital Expenditure

  • Plant additions and expansions

  • Computer and IT investments

  • Machinery and Equipment for production and material handling

Industry Cost Analysis

  • Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight

  • Materials and their percentage share of total material costs

Industry Pricing Analysis

  • Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting

  • Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

Industry Foreign Trade

  • Detailed Import/Export Data by commodities and by countries

  • Mode of Shipment and insurance and freight costs

Industry Structure

  • Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure

  • Establishments: Trends, Employee Statistics, State by State numbers

  • Valued added statistics: industry GDP contribution

Competitive Landscape

  • Industry Concentration: HHI, number of companies, size distributions, market shares

  • Major Players: company profiles and market size ranges

__________________________________________

Definition & Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. This 6-digit NAICS industry (325412) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent codes are: 2834 - Pharmaceutical Preparations ; and 2835 - In Vitro and In Vivo Diagnostic Substances (except in-vitro diagnostic substances).

Revenue, Profitability & Foreign Trade Preview

The industry's revenue for the year 2010 was approximately $137.8 billion USD, with an estimated gross profit of 67.29%. Import was valued at $53.4 billion USD from 84 countries. The industry also exported $28.6 billion USD worth of merchandise to 197 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2010 was $162.6 billion USD.

Report Summary

This 174-page research report covers the industry with a comprehensive view and delivers a depth of information in key areas. Supply and demand data covers U.S. shipments and international trade in the context of the industry's capacity utilization. Industry level income statements, balance sheets, and capital expenditure analysis allow for financial benchmarking. In the cost analysis section, 52 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 31 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. Important trade associations, industry standards, and trade publications are also listed. Over 150 labeled charts and tables are organized to best convey the large amount of data within the report.

Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.

Keywords: adrenal, medicinal, preparations, analgesic, anesthetic, angiourographic, diagnostic, antacid, anthelmintic, antibacterial, antibiotic, antidepressant, antihistamine, antineoplastic, antipyretic, antiseptic, antispasmodic, astringent, barbiturate, barium, vivo, substances, belladonna, birth, control, pills, botanical, extract, except, vitro, diagnostics, cardiac, cathartic, central, nervous, system, stimulant, coagulation, cold, remedies, contraceptive, contrast, media, iodine, cough, drops, medicated, medicines, cyclopropane, dermatological, biological, digestive, digitalis, diuretic, effervescent, salts, electrolyte, eye, ear, fever, remedy, glandular, hematology, hormone, insulin, intravenous, solution, iodinated, laxative, lip, balms, metabolite, mouthwashes, muscle, relaxant, nonprescription, drug, nuclear, medicine, radioactive, isotopes, oral, patent, penicillin, capsules, liniments, ointments, tablets, pituitary, gland, sedative, sodium, chloride, salicylate, suppositories, technetium, thyroid, tincture, tranquilizer, vermifuge, veterinary, vitamin, water, drinking, decontamination, purification, zinc, oxide, abbott, aldrich, allergan, and, bausch, baxter, bristol, cargill, chattem, eli, endo, gamble, genzyme, holdings, hospira, international, johnson, laboratories, lilly, lomb, merck, myers, mylan, nbty, perrigo, pfizer, pharmaceuticals, procter, sigma, squibb, teva, usa

To order this report:

Drug and Medication Industry: Pharmaceutical Preparation Manufacturing Industry in the US and its International Trade [2011 Q3 Edition]

Drug and Medication Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7)
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
7. Access Pharmaceuticals MuGard Included in TRICARE Prescription Drug Coverage
8. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
9. ReportsnReports - Rare Earth Elements Market, Healthcare Cold Chain Logistics Market & Pharmaceutical Market Reports
10. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
11. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):